RecruitingNCT06661278
Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias
Studying Catecholaminergic polymorphic ventricular tachycardia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Principal Investigator
- Catherine E RenwickRoyal Brompton & Harefield NHS Foundation Trust
- Intervention
- Exercise tolerance test(diagnostic_test)
- Enrollment
- 110 enrolled
- Eligibility
- 6-16 years · All sexes
- Timeline
- 2025 – 2025
Study locations (2)
- Great Ormond Street Hospital, London, United Kingdom
- Royal Brompton Hospital, Sutton, United Kingdom
Collaborators
Great Ormond Street Hospital for Children NHS Foundation Trust · Guy's and St Thomas' NHS Foundation Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06661278 on ClinicalTrials.govOther trials for Catecholaminergic polymorphic ventricular tachycardia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07148089A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)Solid Biosciences Inc.
- RECRUITINGPHASE2NCT07263139Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)Agiana Pharmaceuticals
- RECRUITINGPHASE2NCT06658899A Phase 2 Study of CRD-4730 in CPVTCardurion Pharmaceuticals, Inc.
See all trials for Catecholaminergic polymorphic ventricular tachycardia →